Nivolumab in Treating Patients With Recurrent and/or Metastatic Nasopharyngeal Cancer

NCT02339558 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

45

Enrollment

NIH

Sponsor class

Conditions

Nasopharyngeal Nonkeratinizing Carcinoma
Recurrent Nasopharynx Carcinoma
Stage III Nasopharyngeal Carcinoma AJCC v7
Stage IV Nasopharyngeal Carcinoma AJCC v7
Stage IVA Nasopharyngeal Carcinoma AJCC v7
Stage IVB Nasopharyngeal Carcinoma AJCC v7
Stage IVC Nasopharyngeal Carcinoma AJCC v7

Interventions

OTHER: Laboratory Biomarker Analysis
BIOLOGICAL: Nivolumab

Sponsor

National Cancer Institute (NCI)